Chambal Fertilisers and Chemicals (CHAMBLFERT) Investor presentation summary
Event summary combining transcript, slides, and related documents.
Investor presentation summary
20 Mar, 2026Business highlights
Over 40 years in the industry with 3.4 MMTPA urea capacity and ~10% market share, operating three plants at a single location and serving 14 states through 76,000+ retailers and 4,700+ dealers.
Asset-light model for complex fertilisers, crop protection chemicals, and specialty nutrients, with a strong presence in non-subsidized segments under the "Uttam" brand.
Diversification into industrial chemicals with a 2.4 lakh MTPA Technical Ammonium Nitrate (TAN) plant nearing completion.
Strategic joint venture in Morocco (IMACID) for phosphoric acid, contributing stable earnings.
Recognized for operational excellence, energy efficiency, and sustainability with multiple national awards.
Financial performance
Operational income for FY25 was INR 166,462 Mn, with EBITDA of INR 24,842 Mn and PAT of INR 16,568 Mn; EBITDA margin improved to 14.92%.
Net debt to equity is nil as of FY25, reflecting a strong balance sheet and disciplined capital allocation.
ROE and ROCE for FY25 stood at 21% and 25% respectively, indicating robust returns.
Completed a INR 700 crore share buyback, further strengthening capital structure.
Working capital days reduced to 57 in FY25, with a significant drop in finance costs.
Segment overview
Urea accounts for 56% of revenue, complex fertilisers 37%, and crop protection chemicals, specialty nutrients & seeds 7% for 9M-FY26.
Urea production and sales volumes remained stable, with energy-efficient operations and government-backed cost-plus pricing.
Complex fertilisers benefit from the Nutrient Based Subsidy scheme, with ~5-6% market share in DAP, NPK, and MOP.
Crop protection and specialty nutrients segment has a 3% market share, growing at a 19% CAGR, and operates on a higher-margin, asset-light model.
Latest events from Chambal Fertilisers and Chemicals
- Q3 FY26 revenue up 20% and PAT up 12% YoY; new products and TAN project drive growth.CHAMBLFERT
Q3 25/2611 Feb 2026 - EBITDA up 31% YoY, PAT up 18%, with strong crop protection growth and zero long-term debt.CHAMBLFERT
Q1 24/252 Feb 2026 - EBITDA and PAT surged y-o-y, supported by CPCSM growth and interim dividend declaration.CHAMBLFERT
Q2 24/2516 Jan 2026 - Q3 FY25 delivered strong profit and revenue growth, led by agri-initiatives and capacity expansion.CHAMBLFERT
Q3 24/2518 Dec 2025 - EBITDA and PAT rose sharply y-o-y, driven by CPC & SN growth and operational efficiency.CHAMBLFERT
Q4 24/2520 Nov 2025 - Strong revenue and profit growth, new launches, TAN project on track, and interim dividend declared.CHAMBLFERT
Q2 25/266 Nov 2025 - Profits and revenue rose on CPC, SN, and biologicals growth; TAN project 80% complete.CHAMBLFERT
Q1 25/2614 Oct 2025